HIV-1 evades innate immune recognition through specific cofactor recruitment

Nature

Volumn 503, Issue 7476, 2013, Pages 402-405

  Rasaiyaah, Jane ^a   Tan, Choon Ping ^a   Fletcher, Adam J ^a   Price, Amanda J ^b   Blondeau, Caroline ^a   Hilditch, Laura ^a   Jacques, David A ^b   Selwood, David L ^c   James, Leo C ^b   Noursadeghi, Mahdad ^a   Towers, Greg J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; CYCLOPHILIN A; CYCLOSPORIN; GENOMIC RNA; INTERFERON; PATTERN RECOGNITION RECEPTOR; SHORT HAIRPIN RNA;

HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INFECTIVITY; MITOCHONDRIAL DNA; RECOGNITION; SECRETION; TRANSLOCATION;

ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; DNA INTEGRATION; DNA SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; INTERFERON PRODUCTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRUS CAPSID; WILD TYPE;

CAPSID PROTEINS; CYCLOPHILINS; CYCLOSPORINE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON TYPE I; MACROPHAGES; MOLECULAR CHAPERONES; MONOCYTES; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; NF-KAPPA B; NUCLEAR PORE COMPLEX PROTEINS; RECEPTORS, PATTERN RECOGNITION; VIRUS INTERNALIZATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 84888054227     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12769     Document Type: Article

References (32)

1. Lee, K. et al. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 7, 221-233 (2010).
2. Schaller, T. et al. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog. 7, e1002439 (2011).
3. Price, A. J. et al. CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog. 8, e1002896 (2012).
4. Ambrose, Z. et al. Human immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A dependence and impairs macrophage infection. J. Virol. 86, 4708-4714 (2012).
5. Tsang, J. et al. HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation. AIDS 23, 2255-2263 (2009).
6. Besnier, C., Takeuchi, Y.& Towers, G. Restriction of lentivirus inmonkeys. Proc. Natl Acad. Sci. USA 99, 11920-11925 (2002).
7. Iyer, S. R., Yu, D., Biancotto, A., Margolis, L. B. & Wu, Y. Measurement of human immunodeficiency virus type 1 preintegration transcription by using Revdependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates. J. Virol. 83, 8662-8673 (2009).
8. Shi, J., Zhou, J., Shah, V. B., Aiken, C. & Whitby, K. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization. J. Virol. 85, 542-549 (2011).
9. Blair, W. S. et al. HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog. 6, e1001220 (2010).
10. Dettwiler, S., Aringhieri, C., Cardinale, S., Keller, W. & Barabino, S. M. Distinct sequence motifs within the 68-kDa subunit of cleavage factor Im mediate RNA binding, protein-protein interactions, and subcellular localization. J. Biol. Chem. 279, 35788-35797 (2004).
11. Ocwieja, K. E. et al. HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. PLoS Pathog. 7, e1001313 (2011).
12. Sun, L.,Wu, J.,Du, F.,Chen, X.&Chen, Z. J. CyclicGMP-AMPsynthase is acytosolicDNA sensor that activates the type I interferon pathway. Science 339, 786-791 (2013).
13. Gao, D. et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903-906 (2013).
14. Dube, H. et al. A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes. Biochem. J. 441, 901-907 (2012).
15. Liu, J.-P., Ye, L., Wang, X., Li, J.-L. & Ho, W.-Z. Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes. Transpl. Inf. Dis. 13, 24-32 (2011).
16. Yan, N., Regalado-Magdos, A. D., Stiggelbout, B., Lee-Kirsch, M. A. & Lieberman, J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nature Immunol. 11, 1005-1013 (2010).
17. Manel, N. et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467, 214-217 (2010).
18. Morner, A. et al. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently useCCR5but showpromiscuity in coreceptor usage. J. Virol. 73, 2343-2349 (1999).
19. Zhang, F., Hatziioannou, T., Perez-Caballero, D., Derse, D. & Bieniasz, P. D. Antiretroviral potential of human tripartite motif-5 and related proteins. Virology 353, 396-409 (2006).
20. Lee, K. et al. HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6. J. Virol. 86, 3851-3860 (2012).
21. Ruepp, M. D., Schumperli, D.&Barabino, S. M.mRNA39 endprocessingandmore- multiple functions of mammalian cleavage factor I-68. Wiley interdisciplinary reviews. RNA 2, 79-91 (2011).
22. Yang, Q., Gilmartin, G. M. & Doublie, S. The structure of human cleavage factor Im hints at functions beyond UGUA-specific RNA binding: a role in alternative polyadenylation and a potential link to 59 capping and splicing. RNA Biol. 8, 748-753 (2011).
23. Hori, T. et al. A carboxy-terminally truncated human CPSF6 lacking residues encoded by exon 6 inhibits HIV-1 cDNA synthesis and promotes capsid disassembly. J. Virol. 87, 7726-7736 (2013).
24. Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L. & Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnol. 15, 871-875 (1997).
25. Naldini, L. et al. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 272, 263-267 (1996).
26. Négre, D. et al. Characterization of novel safe lentiviral vectors derived fromsimian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther. 7, 1613-1623 (2000).
27. Saeed,A. I. et al.TM4: a free, open-source systemfor microarray datamanagement and analysis. Biotechniques 34, 374-378 (2003).
28. Lynn, D. J. et al. Curating the innate immunity interactome. BMC Syst. Biol. 4, 117 (2010).
29. Butler, S. L., Hansen, M. S. & Bushman, F. D. A quantitative assay for HIV DNA integration in vivo. Nature Med. 7, 631-634 (2001).
30. Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788-792 (2009).
31. Collaborative Computational Project, number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
32. Mikol, V., Kallen, J., Pflugl, G. & Walkinshaw, M. D. X-ray structure of a monomeric cyclophilin A-cyclosporin A crystal complex at 2.1Å resolution. J. Mol. Biol. 234, 1119-1130 (1993).